4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0000950170-25-085748
President and CEO sold 33,683 shares at an average $76.22 ($2,567,481)
- President and CEO acquired 33,683 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YEAMAN KEVIN J President and CEO | 2025-06-10 | Option exercise 10b5-1 | +25,000 | $45.50 | $1,137,500 | 139,725 | I: show line 1 in the form |
| YEAMAN KEVIN J President and CEO | 2025-06-10 | Option exercise 10b5-1 | +8,683 | $64.60 | $560,922 | 148,408 | I: show line 2 in the form |
| YEAMAN KEVIN J President and CEO | 2025-06-10 | Sale 10b5-1 | −33,504 | $76.22 | $2,553,775 | 114,904 | I: show line 3 in the form |
| YEAMAN KEVIN J President and CEO | 2025-06-10 | Sale 10b5-1 | −179 | $76.57 | $13,706 | 114,725 | I: show line 4 in the form |
| Open-market sales · 33,683 sh · avg $76.22 · $2,567,481 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| YEAMAN KEVIN J President and CEO | 2025-06-10 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −25,000 | 160,615 | I: show line 5 in the form | |||||
| YEAMAN KEVIN J President and CEO | 2025-06-10 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −8,683 | 52,817 | I: show line 6 in the form |
Loading xslF345X05/ownership.xml…